Mental Health Clinics in Polson, MT Accepting Medicare
15 Mental Health Clinics found. Showing 1 - 15
 Willow Canyon Counseling Services Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 302 1st St W Ste 203, Polson, MT 59860 Phone: 406-270-3447 |
Jade Creek Counseling Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 2 6th Ave E, Polson, MT 59860 Phone: 360-672-1548 |
Montana Therapy And Consulting Pllc Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 105 4th Ave E, Polson, MT 59860 Phone: 406-412-6768 |
New Mercies 247 Llc Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 32310 Sunrise Dr, Polson, MT 59860 Phone: 406-880-6327 |
Darci Jones, Lcsw, Llc Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 220 Main St, Polson, MT 59860 Phone: 406-885-1188 |
Fairbank Counseling, Pllc Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 2 6th Ave E, Polson, MT 59860 Phone: 406-214-3137 |
Montana Psychiatry Consultation Llc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 500 Mission View Dr, Polson, MT 59860 Phone: 406-552-7799 |
Waxwing Psychotherapy Limited Liability Partnership Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 2 6th Ave E, Polson, MT 59860 Phone: 406-241-1693 |
Dr. Vincent River, P.c. Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 1201 Main St, Suite A, Polson, MT 59860 Phone: 406-883-8126 Fax: 406-883-9226 |
Mind Flow Therapeutics Llc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 2 6th Ave E, Polson, MT 59860 Phone: 406-439-7401 Fax: 833-391-6564 |
Guiding Sage Counseling Clinic - Mental Health Medicare: Medicare Enrolled Practice Location: 302 1st St W, Polson, MT 59860 Phone: 406-219-8824 |
Brave Journey Pllc Social Worker Medicare: Not Enrolled in Medicare Practice Location: 314 1st St E Ste 204, Polson, MT 59860 Phone: 630-219-8019 |
Dalrymple Counseling Services Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 1201 Main St, B, Polson, MT 59860 Phone: 406-883-1718 Fax: 406-204-1207 |
Boule Sophia Llc Clinic - Mental Health Medicare: Medicare Enrolled Practice Location: 41582 Baypoint Rd, Polson, MT 59860 Phone: 406-491-2898 |
Waves Of Change Counseling, Llc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2 6th Ave E, Polson, MT 59860 Phone: 406-450-8082 |
News Archive
First study to examine relationship of risky content in alcohol ads to youth exposure
The content of alcohol ads placed in magazines is more likely to be in violation of industry guidelines if the ad appears in a magazine with sizable youth readership, according to a new study from the Center on Alcohol Marketing and Youth (CAMY) at the Johns Hopkins Bloomberg School of Public Health. Published in the Journal of Adolescent Health, the study is the first to measure the relationship of problematic content to youth exposure, and the first to examine risky behaviors depicted in alcohol advertising in the past decade.
QLT receives exclusive U.S. sales and marketing rights for Visudyne therapy
QLT Inc. ("QLT" or the "Company") today announced that it has restructured its agreement with Novartis Pharma AG ("Novartis") to simplify the relationship, under which, effective January 1, 2010, it will, among other things, receive exclusive U.S. rights to the Visudyne(R) patents to sell and market Visudyne in the U.S. Visudyne, a photosensitizer co-developed with Novartis, is approved worldwide for the treatment of a form of wet age-related macular degeneration ("AMD"), the leading cause of legal blindness in people over the age of 55 in North America and Europe.
Omeros announces initiation of enrollment in OMS824 Phase 2 trial for schizophrenia
Omeros Corporation today announced initiation of enrollment in a Phase 2 clinical trial of OMS824, the company's phosphodiesterase 10 inhibitor. The trial will evaluate the compound's tolerability, safety, pharmacokinetics, potential interactions with concomitant antipsychotic medications, and a battery of cognitive tests in patients with stable schizophrenia.
Eylea can ease vision problems for wet AMD patients
There is no cure for age-related macular degeneration, an eye disease that is the leading cause of vision loss and blindness in older Americans. Last year, the National Institutes of Health reported that two drugs injected into the eyes, Avastin and Lucentis, eased symptoms for sufferers, especially those in the advanced, "wet" stage of the disease, when blood vessels in the eye become swollen and leak fluids in the eye.
Hana Biosciences announces completion of Marqibo pre-NDA meeting with FDA
Hana Biosciences, a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that the Company has completed a pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration (FDA) related to its lead product candidate, Marqibo for the treatment of relapsed/refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL).
› Verified 3 days ago